Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

Blood pressure and metabolic phenotypes in relation to the ADRB1 Arg389Gly and ADRA2B I/D polymorphisms in a White population

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Brodde OE . β-1 and β-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses. Pharmacol Ther 2008; 117: 1–29.

    Article  CAS  Google Scholar 

  2. Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M et al. Identification of a three-amino acid deletion in the α2(B)-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab 1999; 84: 2429–2433.

    CAS  PubMed  Google Scholar 

  3. Small KM, Brown KM, Forbes SL, Liggett SB . Polymorphic deletion of three intracellular acidic residues of the α2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276: 4917–4922.

    Article  CAS  Google Scholar 

  4. Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D et al. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 2006; 27: 808–816.

    Article  CAS  Google Scholar 

  5. Zhang H, Li X, Huang J, Li Y, Thijs L, Wang Z et al. Cardiovascular and metabolic phenotypes in relation to the ADRA2B insertion/deletion polymorphism in a Chinese population. J Hypertens 2005; 23: 2201–2207.

    Article  CAS  Google Scholar 

  6. Siitonen N, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P et al. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 2004; 47: 1416–1424.

    Article  CAS  Google Scholar 

  7. Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M et al. Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord 2001; 25: 1609–1614.

    Article  CAS  Google Scholar 

  8. Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T et al. Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension 2007; 49: 1291–1297.

    Article  CAS  Google Scholar 

  9. Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279–292.

    Article  CAS  Google Scholar 

  10. Lafontan M, Berlan M . Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057–1091.

    CAS  PubMed  Google Scholar 

  11. Mason DA, Moore JD, Green SA, Liggett SB . A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670–12674.

    Article  CAS  Google Scholar 

  12. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73: 366–371.

    Article  CAS  Google Scholar 

Download references


The Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO) is a part of the European Project on Genes in Hypertension (EPOGH), which is endorsed by the European Council for Cardiovascular Research and the European Society of Hypertension. Research included in the present study was partially funded by the European Union (Grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093 InGenious HyperCare, and HEALTH-F4-2007-201550 HyperGenes), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Brussels, Belgium (Grants G.0256.05 and G.0575.06), the Katholieke Universiteit Leuven, Leuven, Belgium (Grants OT/04/34 and OT/05/49), the Else Kröner-Fresenius foundation (P27/05//A24/05//F01), the Heisenberg professorship (Eva Brand) from the Deutsche Forschungsgemeinschaft (Br1589/8-1) and the German Ministry for Education and Science (BMBF 0313040C), Berlin, Germany.

Author information

Authors and Affiliations


Corresponding author

Correspondence to V Tikhonoff.

Additional information

Conflict of interest

None of the authors has a conflict of interest with regard to the data presented in this paper.

Supplementary Information accompanies the paper on the Journal of Human Hypertension website (

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tikhonoff, V., Hasenkamp, S., Kuznetsova, T. et al. Blood pressure and metabolic phenotypes in relation to the ADRB1 Arg389Gly and ADRA2B I/D polymorphisms in a White population. J Hum Hypertens 22, 864–867 (2008).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links